Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Triple Negative Breast Neoplasms 3Pancreatic Neoplasms 2Colorectal Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Melanoma 1Carcinoma, Transitional Cell 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Medullary 1

Interventions

vandetanib 10selpercatinib 5cabozantinib 4pralsetinib 3yeast-CEA vaccine 1rovalpituzumab tesirine 1motesanib diphosphate 1anlotinib 1Sorafenib 1Ranitidine 1Omeprazole 1Melphalan 1Dexamethasone 1Calcium Aluminosilicate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Medullary × yeast-CEA vaccine × Clear all
NCT01856920 2024-07-09

QUILT-3.006 for Recurrent Medullary Thyroid Cancer

NantCell, Inc.

Phase 2 Completed
35 enrolled 9 charts

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡